Clinical Significance of the Relationship between Progression-Free Survival or Postprogression Survival and Overall Survival in Patients with Extensive Disease-Small-Cell Lung Cancer Treated with Carboplatin plus Etoposide
Table 1
Baseline patient characteristics.
Characteristic
Number
Sex
Male/female
52/11
Median age at the time of treatment (years)
67 (50–74)
Performance status
0/1/2/≥3
6/23/19/15
Smoking history
Yes/no
63/0
Number of first-line chemotherapy courses
1/2/3/4/≥5
6/13/4/40/0
Median (range)
4 (1–4)
Number of regimens administered following disease progression after the first-line chemotherapy
